All news

University’s research strength and ecosystem leadership support mission-driven partnerships in the sector.

This year’s QS World University Rankings by Subject provides the latest international recognition for uOttawa and the Faculty of Medicine.

The Faculty of Medicine is pleased to announce the successful recipients of the 2025 University of Ottawa Éric Poulin Centre for Neuromuscular Disease & the Université Claude Bernard Lyon 1 NeuroMyogGene Joint Collaborative Research Program. This joint research program connects the University of Ottawa Éric Poulin Centre for Neuromuscular Disease (CNMD) and the Université Claude Bernard Lyo...

Budget 2025 isn’t subtle. The federal budget’s priorities are loud and clear: strengthening Canada’s economic and political sovereignty in an increasingly unstable world. At a recent University of Ottawa Brown Bag Lunch on public policy, two panelists with very different backgrounds converged on the same message: the pace, scale and expectations around research have been supercharged.

Researchers at the University of Ottawa are unlocking new possibilities in next‑generation photonics, lab‑grown brain tissue and digitized history, backed by more than $17 million through the CFI’s Innovation Fund.

Polanyi Prize winner David Cook is driven by a simple but ambitious goal: to deepen our understanding of gynecologic diseases, develop new treatments, and improve prevention and early detection — particularly for ovarian cancer. He is dedicated to making a difference in women’s health.

The work of Dr. Julie St-Pierre’s lab suggests that forging fresh research insights into mitochondrial biology has strong potential to open new doors in cancer therapy.

New national health data platform gives researchers and institutions secure access to diverse types of health data to accelerate high-performance computing and innovation.

The research landscape is changing fast. It is being shaped by open science, knowledge mobilization and partnerships with industries, communities and governments.

Dr. Jahani-Asl's team aims to translate compelling findings into targeted therapies and better outcomes for patients suffering from glioblastoma.